Synthesis and biological evaluation of chromone-thiazolidine-2,4-dione derivatives as potential α-glucosidase inhibitors

Zheng, Yingying; Li, Mengyu; Wu, Simin; Li, Lu; Xiong, Zhuang; Xu, Xuetao; Zhang, Kun; Wen, Yi

doi:10.1016/j.arabjc.2023.105279

Cited by 6 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[9][10][11][12][13][14][15][16][17][18] Various heterocyclic compounds have been found to show antidiabetic properties by acting as α-glucosidase inhibitors. [19][20][21][22][23] Chromone, known as a class of natural drugs, characterized by a benzoannelated γ-pyrone ring, exhibited the potential to behave as a privileged scaffold for the development of novel molecules in the development of new drugs. These chromone analogs have been found to exhibit a broad spectrum of pharmacological activities, encompassing antibacterial, [24] antioxidant, [25] anticancer, [26] antiinflammatory, [27] and antileishmanial properties.…”

Section: Introductionmentioning

confidence: 99%

Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design

Alharthy,

Khalid,

Fatima

et al. 2024

Archiv der Pharmazie

View full text Add to dashboard Cite

Diabetes is a serious metabolic disorder affecting individuals of all age groups and prevails globally due to the failure of previous treatments. This study aims to address the most prevalent form of type 2 diabetes mellitus (T2DM) by reporting on the design, synthesis, and in vitro as well as in silico evaluation of chromone‐based thiosemicarbazones as potential α‐glucosidase inhibitors. In vitro experiments showed that the tested compounds were significantly more potent than the standard acarbose, with the lead compound 3n exhibiting an IC50 value of 0.40 ± 0.02 μM, ~2183‐fold higher than acarbose having an IC50 of 873.34 ± 1.67 μM. A kinetic mechanism analysis demonstrated that compound 3n exhibited reversible inhibition of α‐glucosidase. To gain deeper insights, in silico molecular docking, pharmacokinetics, and molecular dynamics simulations were conducted for the investigation of the interactions, orientation, stability, and conformation of the synthesized compounds within the active pocket of α‐glucosidase.

show abstract